These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

201 related items for PubMed ID: 7682615

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Inhibition of platelet aggregation by the cAMP-phosphodiesterase inhibitor, cilostamide, may not be associated with activation of cAMP-dependent protein kinase.
    Nishikawa M, Komada F, Morita K, Deguchi K, Shirakawa S.
    Cell Signal; 1992 Jul; 4(4):453-63. PubMed ID: 1329900
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Upregulation of cAMP-specific PDE-4 activity following ligation of the TCR complex on thymocytes is blocked by selective inhibitors of protein kinase C and tyrosyl kinases.
    Michie AM, Rena G, Harnett MM, Houslay MD.
    Cell Biochem Biophys; 1998 Jul; 28(2-3):161-85. PubMed ID: 9515165
    [Abstract] [Full Text] [Related]

  • 25. Mechanisms involved in the antiplatelet activity of rutin, a glycoside of the flavonol quercetin, in human platelets.
    Sheu JR, Hsiao G, Chou PH, Shen MY, Chou DS.
    J Agric Food Chem; 2004 Jul 14; 52(14):4414-8. PubMed ID: 15237945
    [Abstract] [Full Text] [Related]

  • 26. Modulation of cyclic AMP production by signal transduction pathways in preglomerular microvessels and microvascular smooth muscle cells.
    Jackson TC, Mi Z, Jackson EK.
    J Pharmacol Exp Ther; 2004 Jul 14; 310(1):349-58. PubMed ID: 15087474
    [Abstract] [Full Text] [Related]

  • 27. Effects of halothane on the cyclic 3',5'-adenosine monophosphate enzyme system in human platelets.
    Walter F, Vulliemoz Y, Verosky Y, Triner L.
    Anesth Analg; 1980 Nov 14; 59(11):856-61. PubMed ID: 6252800
    [Abstract] [Full Text] [Related]

  • 28. The phospholipase C inhibitor U73122 inhibits phorbol ester-induced platelet activation.
    Lockhart LK, McNicol A.
    J Pharmacol Exp Ther; 1999 May 14; 289(2):721-8. PubMed ID: 10215645
    [Abstract] [Full Text] [Related]

  • 29. Secreted ADP plays a central role in thrombin-induced phospholipase D activation in human platelets.
    Martinson EA, Scheible S, Marx-Grunwitz A, Presek P.
    Thromb Haemost; 1998 Dec 14; 80(6):976-81. PubMed ID: 9869170
    [Abstract] [Full Text] [Related]

  • 30. Thrombin regulates intracellular cyclic AMP concentration in human platelets through phosphorylation/activation of phosphodiesterase 3A.
    Zhang W, Colman RW.
    Blood; 2007 Sep 01; 110(5):1475-82. PubMed ID: 17392505
    [Abstract] [Full Text] [Related]

  • 31. C-phycocyanin, a very potent and novel platelet aggregation inhibitor from Spirulina platensis.
    Hsiao G, Chou PH, Shen MY, Chou DS, Lin CH, Sheu JR.
    J Agric Food Chem; 2005 Oct 05; 53(20):7734-40. PubMed ID: 16190625
    [Abstract] [Full Text] [Related]

  • 32. delta-Opioid receptor activates cAMP phosphodiesterase activities in neuroblastoma x glioma NG108-15 hybrid cells.
    Law PY, Loh HH.
    Mol Pharmacol; 1993 May 05; 43(5):684-93. PubMed ID: 8388986
    [Abstract] [Full Text] [Related]

  • 33. The activity of constitutive nitric oxide synthase is increased by the pathway cAMP/cAMP-activated protein kinase in human platelets. New insights into the antiaggregating effects of cAMP-elevating agents.
    Russo I, Doronzo G, Mattiello L, De Salve A, Trovati M, Anfossi G.
    Thromb Res; 2004 May 05; 114(4):265-73. PubMed ID: 15381390
    [Abstract] [Full Text] [Related]

  • 34. Inhibitory mechanisms of dihydroginsenoside Rg3 in platelet aggregation: critical roles of ERK2 and cAMP.
    Lee WM, Kim SD, Park MH, Cho JY, Park HJ, Seo GS, Rhee MH.
    J Pharm Pharmacol; 2008 Nov 05; 60(11):1531-6. PubMed ID: 18957175
    [Abstract] [Full Text] [Related]

  • 35. Intact cell and cell-free phosphorylation and concomitant activation of a low Km, cAMP phosphodiesterase found in human platelets.
    Macphee CH, Reifsnyder DH, Moore TA, Beavo JA.
    J Cyclic Nucleotide Protein Phosphor Res; 2008 Nov 05; 11(7):487-96. PubMed ID: 2831258
    [Abstract] [Full Text] [Related]

  • 36. Regulation of cAMP Intracellular Levels in Human Platelets Stimulated by 2-Arachidonoylglycerol.
    Signorello MG, Leoncini G.
    J Cell Biochem; 2016 May 05; 117(5):1240-9. PubMed ID: 26460717
    [Abstract] [Full Text] [Related]

  • 37. Ethylene glycol bis(beta-aminoethyl ether)-N,N,N',N'-tetraacetic acid (EGTA) and the tyrphostin ST271 inhibit phospholipase C in human platelets by preventing Ca2+ entry.
    Watson SP, Poole A, Asselin J.
    Mol Pharmacol; 1995 Apr 05; 47(4):823-30. PubMed ID: 7723744
    [Abstract] [Full Text] [Related]

  • 38. A potent and selective inhibitor of cyclic AMP phosphodiesterase with potential cardiotonic and antithrombotic properties.
    Alvarez R, Banerjee GL, Bruno JJ, Jones GL, Littschwager K, Strosberg AM, Venuti MC.
    Mol Pharmacol; 1986 Jun 05; 29(6):554-60. PubMed ID: 3012320
    [Abstract] [Full Text] [Related]

  • 39. U73122 affects the equilibria between the phosphoinositides as well as phospholipase C activity in unstimulated and thrombin-stimulated human and rabbit platelets.
    Vickers JD.
    J Pharmacol Exp Ther; 1993 Sep 05; 266(3):1156-63. PubMed ID: 8396627
    [Abstract] [Full Text] [Related]

  • 40. Effects of a thromboxane synthetase inhibitor and a cAMP phosphodiesterase inhibitor, singly and in combination, on platelet behaviour.
    Sills T, Heptinstall S.
    Thromb Haemost; 1986 Jun 30; 55(3):305-8. PubMed ID: 3018954
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.